From data to deployment: Navigating AI adoption in pharma with Veeva

Digital
Interview at Reuters Pharma EU with Florian Schnappauf, Veeva

It’s safe to say that AI has firmly captured the interest of decision-makers across the industry. But, as the space continues to mature, conversations are shifting from what the technology can do, to how companies can use it most effectively and appropriately.

At the Reuters Pharma Europe conference in Barcelona in April, Deep Dive editor Eloise McLennan spoke with Florian Schnappauf, VP of Commercial Strategy for Veeva AI in Europe, to learn more about what it means to be AI-ready in 2026.

The conversation touches on changing data requirements, the importance of context when working with AI tools, and how companies are preparing for a more digital, AI-enabled healthcare model by 2030. Schnappauf also discusses the Congress at large and his insights from the event.


Market Access
12 questions with: Daniel Kohlstaedt

12 questions with: Daniel Kohlstaedt

Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, with more than 18 years of experience in pharma, talks about his journey through the industry.